Pharma Emerging Markets

Countries Market Data

Having market data available for the specific focus segment of a country is always a good start. However there is much more to analyse before making a quick decision for the priority countries.

The important parameters to look at are including:

  • Complication of market access (Market Entry Strategy, Marketing Mix of competition)
  • Present and future growth potential in the specific product segment
  • Present and future consumer / patient and behaviour
  • Stage of development of the local healthcare system
  • Legal issues, such as patent and intellectual property protection
  • Regulatory aspects (in many countries there are “short cuts” of registration processes available)

Pharma, Consumer Health and Cosmetic Country data
In the following we have published a number of interesting country articles.

CPC International Focus:

CIS/ CEE: RussiaUkraineKazakhstanCzech RepublicPolandRomania

ASIA: IndonesiaThe PhilippinesThailandChinaMalaysiaIndiaVietnamSouth Korea

Latin America: Mexico ColombiaBrazil ArgentinaPeru

Europe: BeNeLuxNorth EuropeAustriaFranceGermanyItalyPortugalSpainSwitzerland

Elsewhere: TurkeyGeorgiaSouth AfricaAustralia – Iran

 

TRIUMPH & Aspirant Countries Data